paclitaxel has been researched along with Erythema in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (20.00) | 18.2507 |
2000's | 12 (48.00) | 29.6817 |
2010's | 5 (20.00) | 24.3611 |
2020's | 3 (12.00) | 2.80 |
Authors | Studies |
---|---|
Chanloung, W; Kasitanon, N; Ketpueak, T; Louthrenoo, W; Nan, KN; Pongsananurak, C | 1 |
Cha, J; Hsu, S; Huang, S; Jennings, E; Lee, JB | 1 |
Franco, L; McLellan, BN; Rzepecki, AK | 1 |
Banner, R; Kahan, J | 1 |
Carlesimo, M; Caro, G; Cortesi, E; D'Arino, A; Fortuna, CM; Grifalchi, F; Pigliacelli, F; Rossi, A; Zancla, S | 1 |
Mutasim, DF; Spicknall, KE | 1 |
Fujii, M; Honma, M; Ishida-Yamamoto, A; Takahashi, I | 1 |
Bahleda, R; Cadranel, J; Ferte, C; Gomez-Roca, C; Loriot, Y; Moldovan, C; Soria, JC; Wislez, M | 1 |
Cruz, A; Hines-Telang, G; Kroumpouzos, G; Temu, T | 1 |
Chiu, HC; Chu, CY; Yang, CH | 1 |
Armstrong, DK; Davidson, NE; Emens, LA; Fetting, JH; Garrett, E; Kennedy, MJ | 1 |
Eich, D; Eich, HT; Krieg, T; Scharffetter-Kochanek, K; Tantcheva-Poor, I | 1 |
Balguerie, X; Chinet, P; Courville, P; Joly, P; Kupfer, I | 1 |
Hatae, M; Hirabayashi, K; Nishida, T; Noda, K; Ogawa, M; Ohashi, Y; Ozaki, M; Takaku, F; Yamamoto, K | 1 |
Berghmans, T; Klastersky, J | 1 |
Burris, HA; Keeling, JH; Lowry, M; Medina, J; Von Hoff, DD; Zimmerman, GC | 1 |
Baker, WJ; Burris, HA; Keeling, JH; Von Hoff, D; Vukelja, SJ | 1 |
de Argila, D; Dominguez, JD; Iglesias, L | 1 |
Abu-Rasmi, R; Drumea, K; Haim, N; Stein, ME | 1 |
Chiu, HC; Chu, CY; Hsiao, GH; Yang, CH; Yang, CY | 1 |
Buekers, TE; Geisler, JP; Raley, J; Sorosky, JI | 1 |
Belinson, J; Kennedy, A; Kulp, B; Markman, M; Peterson, G; Webster, K | 1 |
Ascherman, JA; Attkiss, K; Knowles, SL | 1 |
Lokich, J | 1 |
Arnaouti, T; Giannikos, L; Giannopoulos, A; Kalahanis, N; Karatzas, G; Kosmas, C; Polyzos, A; Sfikakis, PP; Tsavaris, N; Tsigris, C | 1 |
1 review(s) available for paclitaxel and Erythema
Article | Year |
---|---|
Paclitaxel-induced diffuse scleroderma with possible scleroderma-renal crisis: a case report and literature review of taxanes-induced scleroderma.
Topics: Acute Kidney Injury; Erythema; Female; Humans; Male; Paclitaxel; Scleroderma, Diffuse; Scleroderma, Localized; Scleroderma, Systemic; Taxoids | 2022 |
4 trial(s) available for paclitaxel and Erythema
Article | Year |
---|---|
A phase I toxicity and feasibility trial of sequential dose-dense induction chemotherapy with doxorubicin, paclitaxel, and 5-fluorouracil followed by high dose consolidation for high-risk primary breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Breast Neoplasms; Diarrhea; Doxorubicin; Drug Administration Schedule; Erythema; Female; Fluorouracil; Humans; Maximum Tolerated Dose; Middle Aged; Paclitaxel; Sleep Wake Disorders; Time Factors | 2002 |
[A clinical study of YM 294 (rhlL-11) in patients with gynecologic cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Doxorubicin; Drug Administration Schedule; Edema; Erythema; Female; Humans; Interleukin-11; Middle Aged; Ovarian Neoplasms; Paclitaxel; Platelet Count; Recombinant Proteins; Thrombocytopenia; Uterine Cervical Neoplasms | 2005 |
Phase 2 trial of liposomal doxorubicin (40 mg/m(2)) in platinum/paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Doxorubicin; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Erythema; Fallopian Tube Neoplasms; Female; Foot Dermatoses; Hand Dermatoses; Humans; Liposomes; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Stomatitis; Stroke Volume | 2000 |
Phase I clinical trial of weekly combined paclitaxel plus docetaxel in patients with solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Paclitaxel; Taxoids | 2000 |
20 other study(ies) available for paclitaxel and Erythema
Article | Year |
---|---|
Toxic erythema of chemotherapy secondary to gemcitabine and paclitaxel.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Deoxycytidine; Erythema; Female; Gemcitabine; Humans; Intertrigo; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Pancreatic Neoplasms | 2020 |
PATEO syndrome: periarticular thenar erythema with onycholysis.
Topics: Breast Neoplasms; Erythema; Female; Hand-Foot Syndrome; Humans; Joint Diseases; Middle Aged; Onycholysis; Paclitaxel; Syndrome | 2018 |
A localised skin reaction after chemotherapy.
Topics: Antineoplastic Agents, Phytogenic; Drug Eruptions; Endometrial Neoplasms; Erythema; Female; Humans; Middle Aged; Paclitaxel; Radiodermatitis; Spinal Neoplasms | 2018 |
Isochemotopic response: the first case on a scar.
Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cicatrix; Cisplatin; Erythema; Humans; Lung Neoplasms; Male; Neoplasms, Second Primary; Paclitaxel; Thyroid Neoplasms; Thyroidectomy | 2020 |
Localized toxic erythema of chemotherapy during treatment with paclitaxel.
Topics: Antineoplastic Agents, Phytogenic; Carboplatin; Erythema; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms | 2014 |
Toxic erythema with eccrine squamous syringometaplasia induced by nanoparticle albumin-bound paclitaxel.
Topics: Aged; Albumins; Antineoplastic Agents, Phytogenic; Drug Eruptions; Eccrine Glands; Erythema; Humans; Male; Paclitaxel | 2015 |
Pemetrexed-induced pneumonitis: a case report.
Topics: Adrenal Cortex Hormones; Aged; Anti-Infective Agents; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Ciprofloxacin; Cisplatin; Drug Hypersensitivity; Drug Therapy, Combination; Dyspnea; Erythema; Glutamates; Guanine; Humans; Lung; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Paclitaxel; Pemetrexed; Pneumonia; Pulmonary Fibrosis; Recovery of Function; Solitary Pulmonary Nodule | 2009 |
Paclitaxel-induced neutrophilic adverse reaction and acral erythema.
Topics: Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Eruptions; Erythema; Female; Hand Dermatoses; Humans; Leg Dermatoses; Neutrophils; Paclitaxel | 2011 |
Fixed erythrodysaesthesia plaque due to gemcitabine and epirubicin treatment.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Drug Eruptions; Epirubicin; Erythema; Gemcitabine; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Paresthesia; Skin; Taxoids | 2002 |
Acral erythrodysesthesia syndrome caused by intravenous infusion of docetaxel in breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Docetaxel; Drug Eruptions; Erythema; Female; Foot; Hand; Humans; Infusions, Intravenous; Middle Aged; Paclitaxel; Skin Diseases; Sweat Gland Diseases; Syndrome; Taxoids | 2002 |
Scleroderma-like cutaneous lesions induced by paclitaxel: a case study.
Topics: Antineoplastic Agents, Phytogenic; Drug Eruptions; Erythema; Fatal Outcome; Female; Humans; Middle Aged; Paclitaxel; Scleroderma, Localized | 2003 |
Paclitaxel-induced cutaneous toxicity.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cellulitis; Drug Eruptions; Erythema; Extravasation of Diagnostic and Therapeutic Materials; Humans; Lung Neoplasms; Lymphangitis; Male; Paclitaxel; Skin | 1995 |
Prevention of docetaxel-induced erythrodysesthesia with local hypothermia.
Topics: Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Erythema; Female; Humans; Hypothermia, Induced; Paclitaxel; Paresthesia; Taxoids | 1994 |
Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with taxotere.
Topics: Antineoplastic Agents, Phytogenic; Docetaxel; Erythema; Female; Foot Dermatoses; Hand Dermatoses; Humans; Male; Middle Aged; Paclitaxel; Paresthesia; Pyridoxine; Taxoids | 1993 |
Taxol-induced acral erythema.
Topics: Adult; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Erythema; Female; Foot Dermatoses; Hand Dermatoses; Humans; Paclitaxel | 1996 |
Taxol-induced cellulitis after extravasation: a rarely reported event.
Topics: Aged; Antineoplastic Agents, Phytogenic; Blister; Breast Neoplasms; Catheters, Indwelling; Cellulitis; Erythema; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Infusions, Intravenous; Paclitaxel | 1997 |
Fixed erythrodysaesthesia plaque due to intravenous injection of docetaxel.
Topics: Adult; Antineoplastic Agents, Phytogenic; Drug Eruptions; Erythema; Female; Humans; Injections, Intravenous; Male; Middle Aged; Paclitaxel; Paresthesia | 2000 |
Docetaxel extravasation causing significant delayed tissue injury.
Topics: Aged; Antineoplastic Agents, Phytogenic; Blister; Docetaxel; Edema; Erythema; Extravasation of Diagnostic and Therapeutic Materials; Female; Hand Dermatoses; Humans; Paclitaxel; Taxoids | 2000 |
Docetaxel (taxotere) extravasation: a report of five cases with treatment recommendations.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Docetaxel; Edema; Erythema; Extravasation of Diagnostic and Therapeutic Materials; Hand; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Prostatic Neoplasms; Taxoids | 2000 |
Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Spasm; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Drug Hypersensitivity; Edema; Erythema; Female; Greece; Humans; Hypertension; Hypotension; Injections, Intraperitoneal; Injections, Intravenous; Ovarian Neoplasms; Paclitaxel; Pruritus; Retrospective Studies; Tachycardia | 2001 |